3 completed, 1 active not recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Active not recruiting 1 |
Follow Myelodysplastic Syndrome (MDS): new trials by email Literature Review of Myelodysplastic Syndrome (MDS) trials Research Report on Myelodysplastic Syndrome (MDS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome Venetoclax, Azacitidine, Placebo - Myelodysplastic Syndrome (MDS) | Phase 3 | Active not recruiting | AbbVie | 531 | 2020-09-10 | 2026-05-06 |
| Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS NiCord® (omidubicel), Cord Blood Unit - Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Completed | Gamida Cell ltd | 125 | 2016-12-16 | 2026-02-25 |
| Darbepoetin Alfa MDS Companion Protocol Darbepoetin Alfa - Myelodysplastic Syndrome (MDS) | Phase 3 | Completed | Amgen | 9 | 2014-06-12 | 2018-11-14 |
| Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies Miltenyi Biotec CliniMACS, Stem Cell Transplantation, TBI, systemic chemotherapy and antibodies as follows: - Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML) | Phase 3 | Completed | St. Jude Children's Research Hospital | 57 | 2002-03-01 | 2009-01-29 |
Myelodysplastic Syndromes (4) · Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Hematologic Neoplasms (1) · Hemoglobinuria (1) · Hemoglobinuria, Paroxysmal (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myelomonocytic, Juvenile (1) · Lymphoma, Non-Hodgkin (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Bone Marrow Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Myeloid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pathological Conditions, Signs and Symptoms (2) · Anemia (1) · Anemia, Hemolytic (1) · Chronic Disease (1) · Disease Attributes (1)
Antibodies (1) · Azacitidine (1) · Darbepoetin alfa (1) · Stem Cell Transplantation (1) · Whole-Body Irradiation (1) · venetoclax (1)
AbbVie (1) · Amgen (1) · Gamida Cell ltd (1) · St. Jude Children's Research Hospital (1)
United States (3) · Belgium (2) · Brazil (2) · France (2) · Israel (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · Australia (1) · Austria (1) · Canada (1) · China (1) · Czechia (1) · Germany (1)
Gregory A. Hale, M.D. (1) · Mitchell Horwitz, MD (1)
PMID 33811823, PMID 34157093, PMID 37120136, PMID 37703995, PMID 38065202, PMID 41792302
2023 (1)